Skip to main content
DrugPrice

AstraZeneca — Drug Prices & Medicare Spending

AstraZeneca manufactures 21 drugs tracked by Medicare Part D with total spending of $17.6B.

21
Drugs Tracked
$17.6B
Medicare Spending
$115.16
Avg Cost/Claim
86%
Have Generics

AstraZeneca Drugs — Ranked by Medicare Spending

#DrugGeneric NameCost/ClaimGeneric?
1FarxigaDapagliflozin$266.00Yes
2CalquenceAcalabrutinib$10,105.00Yes
3TagrissoOsimertinib$11,591.00No
4SymbicortBudesonide/Formoterol$222.00Yes
5LynparzaOlaparib$10,588.00Yes
6FasenraBenralizumab$2,836.00No
7ImfinziDurvalumab$12,882.00Yes
8Breztri AerosphereBudesonide/Glycopyrrolate/Formoterol$305.00No
9CrestorRosuvastatin$28.00Yes
10BrilintaTicagrelor$229.00Yes
11SeroquelQuetiapine$40.00Yes
12OnglyzaSaxagliptin$126.00Yes
13RosuvastatinRosuvastatin Calcium$9.00Yes
14NexiumEsomeprazole Magnesium$48.00Yes
15QuetiapineQuetiapine Fumarate$27.00Yes
16DapagliflozinDapagliflozin$48.00Yes
17MetoprololMetoprolol Succinate$6.00Yes
18SaphneloAnifrolumab$5,563.00Yes
19OmeprazoleOmeprazole$7.00Yes
20KombiglyzeSaxagliptin/Metformin$197.00Yes
21ByettaExenatide$359.00Yes

Frequently Asked Questions

AstraZeneca manufactures 21 drugs tracked by Medicare Part D, with total annual spending of $17.6B.

Imfinzi (Durvalumab) is the most expensive at $12,882.00 per claim.

18 of 21 AstraZeneca drugs (86%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.